A new cost-effectiveness framework for modeling psoriasis treatments
Graham, C., Mollon, P., Miles, L., & McBride, D. (2015). A new cost-effectiveness framework for modeling psoriasis treatments. Value in Health, 18(3), A20-A20. DOI: 10.1016/j.jval.2015.03.126
As more psoriasis treatments come to market in both new and existing drug classes, health care payers will need assistance in determining the most cost-effective regimen or sequence of regimens to control budgets. We sought to devise a cost-effectiveness modeling structure that will aid in decision making by highlighting differentiating factors between drugs and meet the changing needs of payers.